Cullinan Therapeutics Inc (CGEM)
16.66
+1.03
(+6.59%)
USD |
NASDAQ |
Apr 23, 16:00
16.66
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Total Liabilities (Quarterly): 30.29M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.29M |
| September 30, 2023 | 25.89M |
| June 30, 2023 | 22.41M |
| March 31, 2023 | 29.34M |
| December 31, 2022 | 26.09M |
| September 30, 2022 | 31.11M |
| June 30, 2022 | 62.63M |
| March 31, 2022 | 17.99M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.81M |
| September 30, 2021 | 7.93M |
| June 30, 2021 | 5.813M |
| March 31, 2021 | 9.967M |
| December 31, 2020 | 14.39M |
| September 30, 2020 | 7.806M |
| December 31, 2019 | 140.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.813M
Minimum
Jun 2021
140.37M
Maximum
Dec 2019
29.59M
Average
22.41M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Fate Therapeutics Inc | 137.80M |
| Viking Therapeutics Inc | 20.07M |
| Applied Therapeutics Inc | 71.98M |
| Oscar Health Inc | 2.795B |
| Edgewise Therapeutics Inc | 21.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 484.18M |
| Shareholders Equity (Quarterly) | 453.70M |